Pharmacy Practice and Science Department Highlights: November 2018

(Dec. 3, 2018)

Publications

Porcine Prediction of Pharmacokinetic Parameters in People: A Pig in a Poke? Drug Metabolism and Disposition, 46, 1712-1724 (2018).


Cutaneous adverse effects of diabetes mellitus medications and medical devices: A review. Am J Clin Dermatol. 2018. https://doi.org/10.1007/s40257-018-0400-7.


Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis. Journal of Thrombosis and Thrombolysis 2018;46:145-153 (Erratum published: Journal of Thrombosis and Thrombolysis 10.1007/s11239-018-1777-0)


Treatment complexity in cystic fibrosis (CF): an increasing multifaceted challenge. Pediatr Pulmonol. 2018;53(9):1174-1176


A Pediatric Pharmacy Advocacy Group Practice-Based Research Network: A Report from the Research Committee. J Pediatr Pharmacol Ther. 2018;23(6).


Presentations

Hanna Phan, PharmD, FCCP, FPPAG

  • Medication beliefs among adolescent and adult patients prescribed cystic fibrosis transmembrane protein regulator (CFTR) modulators. Pediatr Pulmonol. 2018;53: 425. Presented at the North American Cystic Fibrosis Conference. Denver, CO. October 2018
  • Pharmacogenomic Principles of Cystic Fibrosis and Interstitial Pulmonary Fibrosis. American College of Clinical Pharmacy (ACCP) Global Conference. Seattle, WA. October 2018.
  • Gastroesophageal Reflux in Cystic Fibrosis. ‘Short Course on Advanced Pharmacology for the CF Provider.’ Presented at the North American Cystic Fibrosis Conference. Denver, CO. October 2018
  • Considerations in the safety and efficacy of dietary supplements intended to promote lung health. Pediatr Pulmonol. 2018; 53: 65-66. Presented at the North American Cystic Fibrosis Conference. Denver, CO. October 2018

Kudos

Nick Ladziak, PharmD

  • Board Certified Ambulatory Care Pharmacist